ArticleStem cell research & therapy2025
Hair follicle-derived melanocyte transplant as a promising treatment strategy for vitiligo.
Article in Stem cell research & therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Transcriptomic Analysis IdentifiesAnimals : an open access journal from MDPI · 2026Article
- Advances in animal models of pigmentary skin disorders.Laboratory animal research · 2026Review
- From Mechanisms to Clinical Practice: Advances in Vitiligo Treatment Across Western Medicine and Traditional Chinese Medicine.Clinical, cosmetic and investigational dermatology · 2026Review
- Emerging cell-based and cell-free therapeutic strategies for vitiligo.Journal of translational autoimmunity · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundThe global incidence of vitiligo has been increasing in recent years, imposing psychological distress and social pressure owing to its refractory and recurrent nature. Traditional therapies often yield unsatisfactory outcomes, necessitating the development of new, effective therapies for vitiligo. In this study, we aimed to evaluate whether transplantation of hair follicle-derived melanocytes can restore pigmentation in depigmented skin associated with vitiligo.
methodsWe developed a method to isolate and culture hair follicle-derived melanocytes. We identified melanocytes at the cellular, protein, and gene levels and established a mouse model of vitiligo using the melanoma/T regulatory cell exhaustion induction method. We used a WOOD's UV lamp, hematoxylin and eosin staining, immunohistochemistry, immunofluorescence, L-DOPA staining, Ferrous sulfate staining, and transmission electron microscopy (TEM) to characterize the vitiligo mouse model. Subsequently, we transplanted hair follicle-derived melanocytes into the mouse model using dermabrasion. Finally, the aforementioned methods determine whether hair follicle-derived melanocytes could survive and recolor vitiligo skin after transplantation.
resultsWe successfully developed a method for isolating and culturing hair follicle-derived melanocytes. Immunofluorescence and flow cytometry results indicated that the cells expressed pigmentation markers such as tyrosinase, tyrosinase-related protein 1, and microphthalmia-associated transcription factor. L-DOPA staining revealed that there was some melanin in the melanocytes, confirming that the melanocytes were functional. Moreover, we successfully established a vitiligo mouse model that recapitulates the key clinical features of vitiligo, including epidermal depigmentation, CD8+/CD4 + T cell infiltration in the skin, and melanocyte loss, confirming that the mouse model reliably mimics human vitiligo. Moreover, vitiligo-afflicted skin was effectively recovered by transplantation of hair follicle-derived melanocytes. Notably, the skin color of the experimental group was similar to that of the control group. Immunofluorescence staining and immunohistochemistry results indicated the presence of melanocytes in the skin of the experimental group, while TEM confirmed that the melanocytes were functional after transplantation.
conclusionTransplantation of hair follicle-derived melanocytes may serve as a more effective therapeutic strategy for vitiligo than currently available methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.